HERON THERAPEUTICS, INC. /DE/ 4
4 · HERON THERAPEUTICS, INC. /DE/ · Filed Mar 9, 2015
Insider Transaction Report
Form 4
Marshall Paul
SVP of Technical Operations
Transactions
- Exercise/Conversion
Common Stock
2015-03-05$9.40/sh+70,000$658,000→ 70,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2015-03-05−70,000→ 140,000 totalExercise: $9.40Exp: 2023-11-01→ Common Stock (70,000 underlying) - Sale
Common Stock
2015-03-05$14.40/sh−50,000$720,000→ 20,000 total - Sale
Common Stock
2015-03-05$15.40/sh−20,000$308,000→ 0 total
Footnotes (3)
- [F1]The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of December 16, 2014.
- [F2]The option granted on November 1, 2013 was a non-plan grant under an agreement with terms substantially the same as applicable to options granted under the Company's 2007 Equity Incentive Plan.
- [F3]Options vested with respect to 52,500 of the underlying shares on November 1, 2014 and pursuant to the terms of the grant, the unvested portion vests pro rata on a monthly basis over the next three years, equaling 4,375 shares per month.